Patent · US Expired

Quinoline inhibitors of cGMP phosphodiesterase

US6576644B2 · kind B2 · utility

22Cited by
11References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 20, 2001
Grant dateJun 10, 2003
Priority date—
Expiry dateAug 20, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D491/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of the formula (I) are useful as inhibitors of cGMP PDE especially Type 5.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.